IDEX Reports Adjusted EPS of $2.68 for the Year and $0.69 for Q4 with Record 2012 Free Cash Flow
Full Year 2012
- Orders increased 7 percent compared to the prior year (+3 percent organic, +5 percent acquisition and -1 percent foreign currency translation).
- Sales increased 6 percent compared to the prior year (+3 percent organic, +5 percent acquisition and -2 percent foreign currency translation).
- Adjusted operating margin of 18.4 percent was up 30 basis points from the prior year.
-
Adjusted net income of
$224 million , which excludes a preliminary non-cash pre-tax impairment charge of$198 million and pre-tax restructuring charges of$32 million , represents an increase of 5 percent compared to the prior year adjusted net income of$214 million . -
Reported net income of
$38 million , which reflects the previously mentioned charges, represents a decrease of 81 percent compared to the prior year reported net income of$194 million . -
Adjusted EPS of
$2.68 was12 cents , or 5 percent, higher than the prior year adjusted EPS of$2.56 . -
Reported EPS of
45 cents , which reflects the previously mentioned charges, represents a decrease of 81 percent compared to the prior year reported EPS of$2.32 . -
Adjusted EBITDA of
$438 million , which represents a record and an 8 percent increase from the prior year, was 22 percent of sales and covered interest expense over 10 times. -
Record free cash flow of
$295 million , which represents a 30 percent increase from the adjusted prior year, was over 132 percent of adjusted net income. -
The Company completed the repurchase of 2.2 million shares of common
stock for
$90 million in 2012.
New orders in the quarter totaled
In the fourth quarter, the Company recorded a preliminary non-cash
goodwill and intangible asset impairment charge of
Excluding the impact of the above-mentioned charges, fourth quarter
adjusted earnings per share was
Free cash flow was
“IDEX is proud to announce in 2012, our 25th anniversary year, we once again achieved record orders, sales and free cash flow. Our flexible operating model drove productivity improvements which, together with structural cost reductions, increased operating margins to 18.4 percent for 2012. I’m pleased with our profit flow-thru of greater than 50 percent on organic revenue growth in 2012.
In the face of uncertain market conditions throughout 2012, our team
executed well. We delivered record free cash flow of
In the fourth quarter we finalized our restructuring activities. No
further restructuring is currently planned. We will continue to drive
productivity through our proven operational excellence capabilities. Our
focus on cost reduction has allowed us to make growth-focused
investments while still netting a
Difficult end market conditions resulted in impairment charges in our Optics & Photonics and Water platforms. Throughout the year, we have aggressively restructured both platforms and are well positioned to take advantage of long-term growth opportunities.
As we enter 2013, our team is focused on executing our strategic
priorities. With over
On a regional basis,
Chairman and Chief Executive Officer
Fluid & Metering Technologies
-
Sales in the fourth quarter of
$212 million reflected a 2 percent decrease compared to the fourth quarter of 2011 (-1 percent organic and -1 percent foreign currency translation). - Operating margin of 21.0 percent represented a 120 basis point improvement compared with the fourth quarter of 2011 primarily due to productivity and cost reduction initiatives.
Health & Science Technologies
-
Sales in the fourth quarter of
$175 million reflected a 6 percent increase compared to the fourth quarter of 2011 (-3 percent organic and +9 percent acquisitions). - Operating margin of 18.4 percent represented a 100 basis point decrease compared with the fourth quarter of 2011 primarily due to lower margins from recently acquired businesses. Sequentially, operating margin improved 110 basis points.
Fire & Safety/Diversified Products
-
Sales in the fourth quarter of
$109 million reflected a 9 percent increase compared to the fourth quarter of 2011 (+10 percent organic and -1 percent foreign currency translation). - Operating margin of 24.2 percent represented a 200 basis point increase compared with the fourth quarter of 2011 primarily due to higher volume and improved productivity.
For the fourth quarter of 2012, Fluid & Metering Technologies contributed 43 percent of sales and 43 percent of operating income; Health & Science Technologies accounted for 35 percent of sales and 31 percent of operating income; and Fire & Safety/Diversified Products represented 22 percent of sales and 26 percent of operating income.
Non-Cash Impairment Charge
Under U.S. GAAP, companies are required to conduct an annual impairment test for each business, or more frequently if an event occurs or circumstances change. An impairment charge is required when the fair value is less than the carrying value of a business.
On
The Company currently estimates the pre-tax charge associated with this
impairment to be in the range of
The non-cash accounting charge will not affect our liquidity, operations or ongoing financial performance.
EBITDA and Free Cash Flow
EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.
EBITDA and Free Cash Flow bridge |
For the Quarter Ended |
For the Year Ended |
||||||||||||||||||||||||||||||
December 31, |
|
September 30, |
December 31, |
|||||||||||||||||||||||||||||
2012 | 2011 | Change | 2012 | Change | 2012 | 2011 | Change | |||||||||||||||||||||||||
Income (Loss) before Taxes |
$ | (135.9 | ) | $ | 67.2 | n/m | % | $ | 70.2 | n/m |
% |
$ |
86.2 |
$ |
273.9 |
(69 |
) |
% |
||||||||||||||
Depreciation and Amortization |
20.4 | 19.3 | 6 | 19.5 | 4 |
78.3 |
72.4 |
8 |
||||||||||||||||||||||||
Interest |
10.5 | 8.4 | 25 | 10.5 | - |
42.3 |
29.3 |
44 |
||||||||||||||||||||||||
EBITDA |
(105.0 | ) | 94.9 | n/m | 100.2 | n/m |
206.8 |
375.6 |
(45 |
) |
||||||||||||||||||||||
CVI Fair Value Inventory |
- | - | - | - | - |
- |
15.8 |
(100 |
) |
|||||||||||||||||||||||
Restructuring charge |
17.9 | 9.4 | 90 | 7.1 | n/m |
32.5 |
12.3 |
n/m |
||||||||||||||||||||||||
Impairment charge |
198.5 | - | 100 | - | 100 |
198.5 |
- |
100 |
||||||||||||||||||||||||
Adjusted EBITDA |
$ | 111.4 | $ | 104.3 | 7 | $ | 107.3 | 4 |
$ |
437.8 |
$ |
403.7 |
8 |
|||||||||||||||||||
Cash Flow from Operating Activities |
$ |
85.7 |
$ |
41.6 |
n/m |
% |
$ |
101.0 |
(15 |
) |
% |
$ |
326.1 |
$ |
217.2 |
50 |
% |
|||||||||||||||
Capital Expenditures |
(7.7 | ) | (7.2 | ) | 7 | (9.4 | ) | (18 | ) |
(35.8 |
) |
(35.2 |
) |
2 |
||||||||||||||||||
Excess Tax Benefit from Stock-Based Compensation |
1.2 |
0.4 |
n/m |
0.8 |
41 |
4.5 |
5.3 |
(16 |
) |
|||||||||||||||||||||||
Free Cash Flow |
79.2 | 34.8 | n/m | 92.4 | (14 | ) |
294.8 |
187.3 |
57 |
|||||||||||||||||||||||
Forward Swap |
- | 38.7 | (100 | ) | - | - |
- |
38.7 |
(100 |
) |
||||||||||||||||||||||
Adjusted Free Cash Flow |
$ | 79.2 | $ | 73.5 | 8 | $ | 92.4 | (14 | ) |
$ |
294.8 |
$ |
226.0 |
30 |
||||||||||||||||||
Conference Call to be Broadcast over the Internet
IDEX will broadcast its fourth quarter earnings conference call over the
Internet on
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries – all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
About IDEX
For further information on
(Tables follow)
IDEX CORPORATION | ||||||||||||||
Condensed Statements of Consolidated Operations | ||||||||||||||
(in thousands except per share amounts) | ||||||||||||||
(unaudited) | ||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||
December 31, | December 31, | |||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||
Net sales | $ | 490,838 | $ | 480,683 | $ | 1,954,258 | $ | 1,838,451 | ||||||
Cost of sales | 287,980 | 287,081 | 1,150,558 | 1,099,778 | ||||||||||
Gross profit | 202,858 | 193,602 | 803,700 | 738,673 | ||||||||||
Selling, general and administrative expenses | 112,059 | 108,218 | 444,490 | 421,703 | ||||||||||
Impairment | 198,519 | - | 198,519 | - | ||||||||||
Restructuring expenses | 17,869 | 9,383 | 32,473 | 12,314 | ||||||||||
Operating income (loss) | (125,589 | ) | 76,001 | 128,218 | 304,656 | |||||||||
Other expense (income) - net | (217 | ) | 442 | (236 | ) | 1,443 | ||||||||
Interest expense | 10,516 | 8,395 | 42,250 | 29,332 | ||||||||||
Income (loss) before income taxes | (135,888 | ) | 67,164 | 86,204 | 273,881 | |||||||||
Provision for income taxes | (16,869 | ) | 19,776 | 48,574 | 80,024 | |||||||||
Net income (loss) | $ | (119,019 | ) | $ | 47,388 | $ | 37,630 | $ | 193,857 | |||||
Earnings per Common Share: | ||||||||||||||
Basic earnings (loss) per common share (a) | $ | (1.45 | ) | $ | 0.57 | $ | 0.45 | $ | 2.34 | |||||
Diluted earnings (loss) per common share (a) | $ | (1.45 | ) | $ | 0.57 | $ | 0.45 | $ | 2.32 | |||||
Share Data: | ||||||||||||||
Basic weighted average common shares outstanding | 82,296 | 82,596 | 82,689 | 82,145 | ||||||||||
Diluted weighted average common shares outstanding | 82,296 | 83,573 | 83,641 | 83,543 | ||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||
(in thousands) | ||||||||||||||
(unaudited) | ||||||||||||||
December 31, | December 31, | |||||||||||||
2012 | 2011 | |||||||||||||
Assets | ||||||||||||||
Current assets | ||||||||||||||
Cash and cash equivalents | $ | 318,864 | $ | 230,259 | ||||||||||
Receivables - net | 256,095 | 252,845 | ||||||||||||
Inventories | 234,950 | 254,258 | ||||||||||||
Other current assets | 71,956 | 51,799 | ||||||||||||
Total current assets | 881,865 | 789,161 | ||||||||||||
Property, plant and equipment - net | 219,161 | 213,717 | ||||||||||||
Goodwill and intangible assets | 1,663,099 | 1,813,588 | ||||||||||||
Other noncurrent assets | 21,265 | 19,641 | ||||||||||||
Total assets | $ | 2,785,390 | $ | 2,836,107 | ||||||||||
Liabilities and shareholders' equity | ||||||||||||||
Current liabilities | ||||||||||||||
Trade accounts payable | $ | 117,341 | $ | 110,977 | ||||||||||
Accrued expenses | 150,176 | 130,696 | ||||||||||||
Short-term borrowings | 7,335 | 2,444 | ||||||||||||
Dividends payable | 16,575 | 14,161 | ||||||||||||
Total current liabilities | 291,427 | 258,278 | ||||||||||||
Long-term borrowings | 779,241 | 806,366 | ||||||||||||
Other noncurrent liabilities | 249,724 | 258,328 | ||||||||||||
Total liabilities | 1,320,392 | 1,322,972 | ||||||||||||
Shareholders' equity | 1,464,998 | 1,513,135 | ||||||||||||
Total liabilities and shareholders' equity | $ | 2,785,390 | $ | 2,836,107 |
IDEX CORPORATION | ||||||||||||||||
Company and Business Group Financial Information | ||||||||||||||||
(dollars in thousands) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||
December 31, (b) | December 31, (b) | |||||||||||||||
2012 |
2011 (c) |
2012 |
2011 (c) |
|||||||||||||
Fluid & Metering Technologies | ||||||||||||||||
Net sales | $ | 211,855 | $ | 216,920 | $ | 833,288 | $ | 831,287 | ||||||||
Operating income (d) | 44,455 | 42,879 | 180,630 | 167,679 | ||||||||||||
Operating margin | 21.0 | % | 19.8 | % | 21.7 | % | 20.2 | % | ||||||||
Depreciation and amortization | $ | 7,445 | $ | 7,527 | $ | 29,637 | $ | 32,368 | ||||||||
Capital expenditures | 3,784 | 2,723 | 13,535 | 12,543 | ||||||||||||
Health & Science Technologies | ||||||||||||||||
Net sales | $ | 174,661 | $ | 165,281 | $ | 695,235 | $ | 607,900 | ||||||||
Operating income (d) (e) | 32,214 | 32,086 | 122,708 | 123,967 | ||||||||||||
Operating margin | 18.4 | % | 19.4 | % | 17.6 | % | 20.4 | % | ||||||||
Depreciation and amortization | $ | 10,687 | $ | 9,369 | $ | 39,981 | $ | 30,055 | ||||||||
Capital expenditures | 2,704 | 3,020 | 13,140 | 12,938 | ||||||||||||
Fire & Safety/Diversified Products (c) | ||||||||||||||||
Net sales | $ | 108,880 | $ | 99,611 | $ | 437,053 | $ | 402,425 | ||||||||
Operating income (d) | 26,296 | 22,156 | 104,461 | 91,128 | ||||||||||||
Operating margin | 24.2 | % | 22.2 | % | 23.9 | % | 22.6 | % | ||||||||
Depreciation and amortization | $ | 1,881 | $ | 1,955 | $ | 7,107 | $ | 8,516 | ||||||||
Capital expenditures | 1,471 | 1,059 | 6,654 | 5,644 | ||||||||||||
Company | ||||||||||||||||
Net sales | $ | 490,838 | $ | 480,683 | $ | 1,954,258 | $ | 1,838,451 | ||||||||
Operating income (d) | 90,799 | 85,384 | 359,210 | 332,770 | ||||||||||||
Operating margin | 18.5 | % | 17.8 | % | 18.4 | % | 18.1 | % | ||||||||
Depreciation and amortization (f) | $ | 20,374 | $ | 19,270 | $ | 78,312 | $ | 72,386 | ||||||||
Capital expenditures | 8,254 | 7,412 | 35,520 | 34,548 | ||||||||||||
(a) | Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share. | |||||||||||||||
(b) | Three and twelve month data includes acquisitions of Matcon (July 2012), ERC (April 2012), CVI Melles Griot (June 2011), Microfluidics (March 2011) and Advanced Thin Films (January 2011) in the Health & Science Technologies segment from the date of acquisition. | |||||||||||||||
(c) | Financial data for 2011 has been revised to reflect the transfer of our Trebor business unit from the Health & Science Technologies segment to the Fluid & Metering Technologies segment as well as the movement of the Dispensing Equipment segment into the Fire & Safety/Diversified Products segment. | |||||||||||||||
(d) | Group operating income excludes unallocated corporate operating expenses while both Group and Company operating income excludes the impairment charge in 2012 (for the Fluid & Metering Technologies and Health & Science Technologies segments) and restructuring related charges for 2012 and 2011. | |||||||||||||||
(e) | Operating income excludes $15.8 million for the twelve months ending December 31, 2011 related to a non-cash acquisition fair value inventory charge. | |||||||||||||||
(f) | Depreciation and amortization excludes amortization of debt issuance expenses. |
IDEX Corporation | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months ended December 31, 2012 | ||||||||||||||||
Non-GAAP | ||||||||||||||||
GAAP As | Restructuring | Impairment | Adjusted (ex | |||||||||||||
Reported | Expense | Charge | charges) | |||||||||||||
Net sales | $ | 490,838 | $ | 490,838 | ||||||||||||
Cost of sales | 287,980 | 287,980 | ||||||||||||||
Gross profit | 202,858 | 202,858 | ||||||||||||||
SG&A | 112,059 | 112,059 | ||||||||||||||
Impairment | 198,519 | (198,519 | ) | - | ||||||||||||
Restructuring expenses | 17,869 | (17,869 | ) | - | ||||||||||||
Operating income (loss) | (125,589 | ) | 17,869 | 198,519 | 90,799 | |||||||||||
Other expense (income) - net | (217 | ) | (217 | ) | ||||||||||||
Interest expense | 10,516 | 10,516 | ||||||||||||||
Income (loss) before income taxes | (135,888 | ) | 17,869 | 198,519 | 80,500 | |||||||||||
Provision (benefit) for taxes | (16,869 | ) | 5,182 | 35,008 | 23,321 | |||||||||||
Net income (loss) | $ | (119,019 | ) | $ | 12,687 | $ | 163,511 | $ | 57,179 | |||||||
Earnings (loss) per common share | $ | (1.45 | ) | $ | 0.15 | $ | 1.99 | $ | 0.69 | |||||||
Twelve Months ended December 31, 2012 | ||||||||||||||||
Non-GAAP | ||||||||||||||||
GAAP As | Restructuring | Impairment | Adjusted (ex | |||||||||||||
Reported | Expense | Charge | charges) | |||||||||||||
Net sales | $ | 1,954,258 | $ | 1,954,258 | ||||||||||||
Cost of sales | 1,150,558 | 1,150,558 | ||||||||||||||
Gross profit | 803,700 | 803,700 | ||||||||||||||
SG&A | 444,490 | 444,490 | ||||||||||||||
Impairment | 198,519 | (198,519 | ) | - | ||||||||||||
Restructuring expenses | 32,473 | (32,473 | ) | - | ||||||||||||
Operating income | 128,218 | 32,473 | 198,519 | 359,210 | ||||||||||||
Other expense (income) - net | (236 | ) | (236 | ) | ||||||||||||
Interest expense | 42,250 | 42,250 | ||||||||||||||
Income before income taxes | 86,204 | 32,473 | 198,519 | 317,196 | ||||||||||||
Provision for taxes | 48,574 | 9,547 | 35,008 | 93,129 | ||||||||||||
Net income | $ | 37,630 | $ | 22,926 | $ | 163,511 | $ | 224,067 | ||||||||
Earnings per common share | $ | 0.45 | $ | 0.27 | $ | 1.95 | $ | 2.68 |
Source:
IDEX Corporation
Investor Contact:
Heath Mitts
Vice
President – Chief Financial Officer
(847) 498-7070